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DObjective: Left ventricular end-diastolic volume is decreased and ejection fraction is increased after surgical
ventricular reconstruction; however, the impact on left ventricular stroke volume is not well established.
Methods: We analyzed 248 consecutive patients who underwent surgical ventricular reconstruction at a single
center. There were 14 perioperative deaths (5.6%). The 234 surviving patients had pre- and postsurgical ventric-
ular reconstruction echocardiographic measurement of end-diastolic volume, end-systolic volume, and stroke
volume, each indexed to body size and ejection fraction. A total of 120 patients had echocardiography data at
follow-up (median 8 months).
Results: Overall, surgical ventricular reconstruction resulted in reductions in end-diastolic volume index (–30%
 18%) and end-systolic volume index (–37% 20%), and increases in ejection fraction (21% 18% relative
increase). However, stroke volume index decreased from 35  8 mL/m2 preoperatively to 28  7 mL/m2 early
postoperatively (a 17% 24% relative reduction, P<.0001); 165 patients (71%) exhibited a decrease and 69 pa-
tients (29%) exhibited an increase or no change in stroke volume index after surgical ventricular reconstruction.
Stroke volume index reduction was strictly related to end-diastolic volume reduction. Patients who initially had
a stroke volume index decrease showed recovery, so that at the time of chronic follow-up there was no significant
difference between the groups. Notably, 4-year survival was approximately 85% and did not differ between
patients with an increase or decrease in stroke volume index (P ¼ .383).
Conclusions: Although surgical ventricular reconstruction uniformly results in an impressive decrease in end-
diastolic volume index and increase in ejection fraction, seemingly indicating beneficial remodeling and
improved pump function, systolic volume index, which more directly indexes cardiac pump function, frequently
decreases after surgical ventricular reconstruction. Further study is needed to identify baseline characteristics that
predict those patients in whom cardiac performance is enhanced by surgical ventricular reconstruction and to
clarify whether there is a beneficial impact on exercise tolerance and cardiac output at peak exercise. (J Thorac
Cardiovasc Surg 2010;140:1325-31)Supplemental material is available online.
Until recently, surgical ventricular reconstruction (SVR) for
ischemic cardiomyopathy, as described by Dor and col-
leagues,1,2 was being performed with increasing frequency
to resize and reshape the dilated left ventricle (LV) caused
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The Journal of Thoracic and Carend-systolic volume (ESV) by as much as 30% or more is
typically achieved,2 far greater than the degree of reverse re-
modeling achieved with any other heart failure treatment.
Furthermore, SVR also results in an immediate reduction
in chamber radius, which decreases myocardial systolic
and diastolic wall stresses (Laplace’s Law) and therefore
has potential, similar to pharmacologic therapies that reduce
myocardial afterload and preload, to induce myocellular and
molecular reverse remodeling.3,4 However, with the recent
publication of the multinational Surgical Treatment for
Ischemic Heart Failure (STICH) trial,5 which showed no dif-
ference in mortality, hospitalizations, symptoms, or exercise
tolerance in the overall population treated with coronary
artery bypass grafting (CABG) alone or CABG plus SVR,
it is expected that the number of SVR procedures will
decline significantly.
Before release of the STICH study results, several
theoretic and experimental studies explored the impact of
SVR on LV pump function.6-12 Although ejection fraction
(EF) consistently increases after SVR, it has been shown
that this does not have the usual meaning of an increase indiovascular Surgery c Volume 140, Number 6 1325
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CABG ¼ coronary artery bypass grafting
EDV ¼ end-diastolic volume
EDVI ¼ end-diastolic volume index
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ESV ¼ end-systolic volume
ESVI ¼ end-systolic volume index
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NYHA ¼ New York Heart Association
STICH ¼ Surgical Treatment for Ischemic
Heart Failure
SVI ¼ stroke volume index
SVR ¼ surgical ventricular reconstruction
WMSI ¼ wall motion score index
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DLV pump function.6,8 Among the other indexes of pump
function explored, there were load-independent (eg, end-
systolic pressure-volume relations) and load-dependent
(eg, stroke volume) indexes. Regardless of which of these
indexes was examined, the results suggested that pump func-
tion could be increased, unchanged, or decreased, depending
on the relative characteristics (dyskinetic, akinetic, or hypo-
kinetic, respectively) and amount of the LV wall excluded
during SVR. Because it was anticipated that a majority of pa-
tients to be included in STICH would have akinetic scars, it
was suggested prospectively that the study would be neutral
with regard to clinical outcomes, which turned out to be the
case.5,6 However, whether there is a direct link between the
impact of SVR on LV function and clinical outcomes is
speculative and remains an important unresolved question.
Therefore, the purpose of the present study was to deter-
mine how SVR affects stroke volume and, most important,
to test whether acute postoperative changes in SV are asso-
ciated with clinical outcome after SVR.MATERIALS AND METHODS
This is a retrospective case review study of 248 patients with previous
anterior myocardial infarction who were referred for SVR at the San Donato
Hospital between October 2001 and July 2008 and who had echocardio-
grams before surgery and at the time of hospital discharge. A total of 120
of these patients also had echocardiograms performed at a median of 8
months after surgery. Indications for SVR were symptomatic heart failure,
angina, or a combination of the 2; concomitant coronary grafting was per-
formed in 94% of cases. Patients with moderate-to-severe mitral regurgita-
tion were excluded from the present analysis; this excludes the possibility
that postoperative SV estimates from LV volumes were artifactually de-
creased because of the increased afterload after mitral repair or replacement.
LV volumes were calculated from biplane echocardiographic images (4-
chamber and 2-chamber views) using the Simpson method. SV was defined
as the difference between end-diastolic volume (EDV) and ESV, and, in the
absence of mitral regurgitation, it represents the effective output per beat. EF
was defined as SV/EDV3 100. LV volume measurements were indexed to
body surface area and expressed as end-diastolic volume index (EDVI),
end-systolic volume index (ESVI), and stroke volume index (SVI). We1326 The Journal of Thoracic and Cardiovascular Surare aware of the limitation of biplane echocardiography to measure LV
volumes, especially in ischemic dilated heart disease and in a procedure
that markedly changes LV geometry; however, the echocardiography study
is performed both before and after surgery by the same experienced cardi-
ologist, well trained in the evaluation of candidates for SVR. When there
are difficulties to identify the endocardial border, we use contrast echocar-
diography to improve the vision of the cavity, and when the acoustic win-
dow is poor, we perform cardiac magnetic resonance but do not report the
echocardiography data on the registry. Follow-up was conducted periodi-
cally through telephone interview with the family or the family doctor,
and if the telephone interview failed, we contacted the regional death regis-
try. The study was approved by our ethical committee, and patients gave
their informed consent.
Surgical Procedure
Details of the surgical technique have been reported.2,12,14 In brief, the
procedure is conducted on arrested hearts with antegrade crystalloid or
blood cold cardioplegia. Complete coronary grafting is first performed,
and then the ventricle is opened and an intraventricular device (TRI-SVR
Chase Medical, Richardson, Tex) is inflated in the ventricle, according to
body surface area (50–60 mL/m2), to resize and reshape the LV. The new
apex is formed around the shaper, which is removed before closing the
ventricle, with or without a patch.
Statistical Analysis
The results are expressed as mean  standard deviations unless other-
wise indicated. Statistical analysis included an analysis of variance with
Bonferroni corrections for within-group comparisons or an independent var-
iable Student t test for comparison between 2 groups. Paired t testing was
used to compare pre- and postoperative changes. Kaplan–Meier analysis
was used to assess survival, and log-rank test was used to compare groups.
The SPSS software (SPSS Inc, Chicago, Ill) was used for statistics.
RESULTS
Of the 248 patients included in the study who underwent
SVR during the reporting period, 234 (95%) survived to
hospital discharge and had a predischarge echocardiogram.
There was an approximately 5% perioperative mortality
(14 patients) during the first 30 days. Comparison of clinical
characteristics (Table E1) showed that patients who survived
were slightly younger, had lower proportion of New York
Heart Association (NYHA) class III or IV, and had higher
EFs compared with patients who died perioperatively. There
were no significant differences in gender, background med-
ical therapies, and basic features of the surgical procedure
between these 2 groups. There were no differences in heart
rate that might have influenced SVI changes after SVR
(66  9 vs 68  8, P ¼ .658) or in the rate of hypertension
among risk factors (57% vs 52%, P ¼ .662). Baseline
angiotensin-converting enzyme inhibitor, b-blocker, and
diuretic use was less than in most current heart failure trials,
mainly because of the early start date of the study, which was
before widespread use of these agents and the inclusion of
patients with NYHA class II symptoms.
Overall, SVR resulted in reductions in EDVI (–30% 
18%) and ESVI (–37%  20%), and increases in EF
(21%  18% relative increase) (P .0001), but a decrease
in SVI (–17% 24%) (Figure 1). For the group as a whole,
SVI decreased from 35  8 mL/m2 preoperatively togery c December 2010
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FIGURE 1. Postoperative changes in EDVI, ESVI, SVI, and EF in the
overall study population. Despite increases in EF, SVI decreased. See text
for details. All changes are significant at P<.001. EDVI, End-diastolic vol-
ume index; ESVI, end-systolic volume index; SVI, stroke volume index; EF,
ejection fraction.
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sponse was heterogeneous in that SVI decreased in 165
(71%) of the patients and increased in 69 (29%) of the pa-
tients after SVR. The relationship between changes in EDVI
and changes in EF and SVI are summarized in Figure 2, with
variables expressed as percent changes from baseline. For
the group as a whole, the greater the reduction in EDVI,
the greater the increase in EF and the greater the decrease
in SV. Changes in EF were highly correlated to changes in
EDVI (r ¼ 0.89). In comparison, the relationship between
changes in EDVI and SVI had a lower correlation coefficient
(r ¼ 0.63), and there was significantly more scatter around
the line of regression. It is seen that although the trend was
for SVI to decrease as EDVI decreased, even with large re-
ductions in EDVI there were some patients in whom SVI
was unchanged or even increased.
To explore if there was any systematic impact of the ab-
solute size of the heart at baseline on the impact of SVR on
postoperative LV size and function, patients were grouped
into quintiles of baseline EDVIs as follows: category I,FIGURE 2. The relationships between changes in EDVI and changes in EF and S
were highly correlated to changes in EDVI (r ¼ 0.89). In comparison, the relatio
(r ¼ 0.63), and there was significantly more scatter around the line of regression
increased. EDVI, End-diastolic volume index; SVI, stroke volume index; EF, ej
The Journal of Thoracic and Car 86 mL/m2; category II, 86–105 mL/m2; category III,
106–126 mL/m2; category IV, 127–169 mL/m2; and cate-
gory V,  169 mL/m2. The pre- and postoperative LV
size and function data are summarized in Table 1 according
to these categories. In all categories, SVR significantly re-
duced ESVI and EDVI and increased EF. However, except
for category I (relatively smaller hearts at baseline), average
SVI decreased in all categories (7–11 mL/m2), and there
was a trend for the decrease in SVI to be greater in the larger
hearts.
Long-Term Changes in Left Ventricular Size and
Function
In 120 patients, echocardiograms were available at
baseline, 1 week post-SVR, and a median of 8 months (range
4–58 months) after SVR. The patients excluded from the
present analysis (because they did not have echocardiogra-
phy control at follow-up) did not differ in clinical and
hemodynamic profiles from the 120 patients with echocardi-
ography control. Patients in whom SV decreased initially
had larger stroke volumes at baseline compared with those
in whom SV increased initially (Figure 3); they also had
larger EDVI and ESVI and greater EF (35%  7% vs
31%  8%; P .004) However, the SVI reduction was tem-
porary, and patients in whom SV had initially decreased
showed recovery, so that at the time of chronic follow-up
there was no significant difference in SV between the groups
(Table 2). The reduction in EDVI and ESVI persisted along
time (EDVI from 114 42 mL/m2 to 82 20 mL/m2; ESVI
from 76 37 mL/m2 to 49 18 mL/m2, P .001 vs baseline),
indicating a persistent benefit. These findings indicate that
different baseline loading conditions may impact the
response of cardiac function to SVR.
Impact of Properties of Excluded Region
Prior studies have suggested that the impact of SVR on
stroke volume will vary with the amount and materialVI variables are expressed as percent changes from baseline. Changes in EF
nship between changes in EDVI and SVI had a lower correlation coefficient
. Notably, there were many patients in whom SVI was unchanged or even
ection fraction.
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TABLE 1. Impact of surgical ventricular restoration on left ventricular size and function with patients grouped in quintiles of preoperative end-
diastolic volume index
Category I
EDVIpre  86
N ¼ 30
Category II
86<EDVIpre  105
N ¼ 60
Category III
105<EDVIpre  126
N ¼ 67
Category IV
126<EDVIpre  169
N ¼ 64
Category V
EDVIpre  169
N ¼ 13
Pre Post Pre Post Pre Post Pre Post Pre Post
EDVI (mL/m2) 73  9 59  15* 95  5 69  18* 114  6 73  16* 142  13 93  23* 200  34 98  21*
ESVI (mL/m2) 44  8 32  11* 61  7 41  14* 78  10 45  13* 101  14 61  19* 159  33 67  18*
SVI (mL/m2) 30  7 27  7 34  5 27  7* 37  7 28  7* 41  8 31  7* 41  9 30  5*
EF% 40  7 46  10* 35  6 41  8* 32  7 38  8* 29  6 35  6* 21  6 32  6*
EDVI, End-diastolic volume index; ESVI, end-systolic volume index; SVI, stroke volume index; EF, ejection fraction. *P< .001 vs preoperatively.
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Dproperties of the scar that is excluded (akinetic vs dyski-
netic). We used a standard semiquantitative 4-point wall
motion score index (WMSI) to characterize the segment(s)
that was surgically excluded and related this to the change
in stroke volume. The WMSI scale was as follows:
1 ¼ normal wall motion, 2 ¼ hypokinesia, 3 ¼ akinesia,A
B
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FIGURE 3. A total of 120 patients were followed for a median of 8
months. Patients with an initial decrease in SV had larger stroke volumes
at baseline compared with patients with an initial increase in SV. However,
patients with an initial decrease in SV showed recovery, so at the time of
chronic follow-up, there was no significant difference in SV between the
groups. *P< .001 between groups. SV, Stroke volume.
1328 The Journal of Thoracic and Cardiovascular Surand 4¼ dyskinesia. A significant inverse correlation between
WMSI and SVI changes (Pearson r ¼0.2741; 95% confi-
dence interval,0.4797 to0.03998;P¼ .026) was observed;
thus, the higher the WMSI (ie, the more dyskinetic the seg-
ment) the less the reduction in SVI after SVR. Furthermore,
the WMSI of the patients with increased SVI (2.52  0.30)
was significantly greater than in the patients with decreased
SVI (2.35  0.28, P ¼ .01).Survival and Clinical Correlates
We assessed whether early SV increase or decrease
affected clinical status or survival after SVR and found
NYHA functional class improved at follow-up, indepen-
dently of whether SVI decreased (from 2.4  0.7 to 1.6 
0.7, P< .0001) or increased (from 2.4  0.7 to 1.5  0.6,
P< .0001). Moreover, with an average of 43  24 months
follow-up, there was no difference in survival between these
2 groups (Figure E1, P ¼ .383, 97% follow-up). Overall
survival at 4 years was approximately 90%; even if the
approximately 5% perioperative mortality is included, theTABLE 2. Hemodynamic changes at three time intervals
SVI decreased SVI increased P value
EDVI (mL/m2)
Pre 114  42 100  30 .02
Early post 71  20 82  21 .001
Late post 82  20 91  28 .09
ESVI (mL/m2)
Pre 76  37 70  29 .524
Early post 43  16 48  18 .07
Late post 49  17 57  27 .08
SVI (mL/m2)
Pre 38  9 29  6 .001
Early post 27  6 34  7 .001
Late post 33  7 33  7 .724
EF (%)
Pre 35  8 31  8 .004
Early post 40  9 42  9 .524
Late post 41  8 40  10 .734
SVI, Stroke volume index; EDVI, end-diastolic volume index; ESVI, end-systolic
volume index; EF, ejection fraction.
gery c December 2010
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survival.
DISCUSSION
The results of the present study show that despite a consis-
tent increase in EF, resting SV frequently decreases after
SVR. In fact, data pooled from the entire cohort showed an
average 7 mL/m2 (17%) decrease in resting SV. Prior clinical
studies of SVR have emphasized the decrease in EDV and
ESV and the increase in EF that are always observed after
SVR. It was these specific observations that largely fueled
clinical enthusiasm for SVR. However, it has been empha-
sized that the meaning of the changes in these variables is
not the same as it is when they are achieved by pharmacologic
or device-based therapies in which reductions in LV volumes
and mass result from regression of hypertrophy at a cellular
level.6,7 Rather than focusing on the impact on EF, EDV,
and ESV, however, it has been suggested that attention be
directed to the impact of SVR on variables that more
directly index pump function, such as cardiac work, stroke
volume, and cardiac output.
Overall, SVR was performed with relative safety (5%
perioperative mortality) and high long-term survival. Pa-
tients who died perioperatively were older and had clinical
and echocardiographic evidence of worse heart failure com-
pared with the remaining patients. However, one of the most
important aspects of the current findings is that overall sur-
vival was not affected by whether stroke volume increased
or decreased after SVR. Although there is no a priori reason
to expect that survival would be linked with a change in rest-
ing SV, it is reasonable to be concerned that there could have
been negative consequences.
A detailed review of the literature11 indicates that the
current findings regarding a reduction in SV from SVR
are not unexpected. A survey of 31 articles in which LV vol-
umes where reported pre- and post-SVR reveals that several
investigators noted a reduction in SV10-17 and others
reported an increase in SV.18-24 It is noteworthy that
although these articles always reported pre- and post-SVR
values for LVEDVs and EFs, values for SVs were not typ-
ically reported, and, more specifically, changes in SV were
almost never reported (or discussed). Because of the lack of
such reporting, a formal meta-analysis of the impact of SVR
on SVI is not possible. Inconsistent reporting of data com-
pleteness, differences in volume measurement techniques,
and significant differences in the timing of postoperative
volume measurements further complicate performance of
such a meta-analysis. Overall, our estimates of mean post-
SVR changes in SV reported in the literature11 range from
an increase of 15 mL to decreases of 15 mL or greater
with, as noted above, a majority of studies showing reduc-
tions. This survey of the literature indicates that the findings
of our current study are not inconsistent with the majority of
prior reports.The Journal of Thoracic and CarThe present study analyzed the early changes in SVI after
SVR and attempted to understand the apparent paradox of
improved volumes reduction and EF with the frequently ob-
served reduction in stroke volume after SVR. Our data indi-
cate that ‘‘early’’ stroke volume reduction is transitory
(Figure 3) and is linked, at least partially, to preoperative
ventricular properties. Patients with an SVI decrease had
a higher preoperative stroke volume and larger EDV.
Notably, these patients also had a lower WMSI, indicating
significantly less wall motion abnormalities. As detailed pre-
viously,6 this fits with the theory showing that with regard to
the impact on pump function, SVR could be detrimental in
patients whose wall to be excluded is hypokinesia, would
be neutral in patients whose wall to be excluded is akinetic,
and would be beneficial in patients whose wall to be ex-
cluded is dyskinetic. Thus, the higher the WMSI, the greater
the expected improvement in stroke volume.
Limitations
There are several limitations of the present study. First, we
only measured echocardiograms at rest. If SVR chronically
reduces wall stress and improves inotropic reserve, chrono-
tropic competence, and myocardial force-frequency rela-
tions, there could be a disparity between an impact at rest
and during stress. It would be interesting to pursue these hy-
potheses in future studies. Second, our most complete data
set concerning the impact of SVR on LV size and function
was in the early postoperative period, with a smaller data-
base at long-term follow-up. Comparison of resting LV
size and function between preoperative and early postopera-
tive conditions provides important information about the
direct effects of the surgery. It would have been ideal to
have a more thorough database at a consistent, long-term fol-
low-up period. However, because this was a registry study,
we were limited to information obtainable in the routine
course of care of these patients, which did not always include
long-term echocardiograms. In addition, we did not collect
information about patient blood pressure at the time of echo-
cardiogram, at either short term or long term. Significant
changes in blood pressure could have an impact on stroke
volume and thus on the conclusions of the present study.
Evaluation of load-independent indexes of ventricular
contractility could have provided information significantly
beyond that provided simply by EDV, SV, and EF. Such
indexes typically evaluate SV, stroke work, end-systolic
pressures, and ESVs over a range of filling conditions, infor-
mation that is not available from the present cohort. Such in-
formation has been provided in prior studies,10 mainly in the
short-term period after surgery. These studies confirm
important and specific changes in LV systolic and diastolic
properties.6 In this regard, it would be most interesting to in-
vestigate whether specific changes in such load-independent
indexes correlate with outcome, which has not been done
thus far. Third, the percentage of patients prescribeddiovascular Surgery c Volume 140, Number 6 1329
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low compared with current standards, and this may have
affected both SV (another reason why load-independent in-
dexes of LV function would be ideal) and clinical outcomes.
The low use of these drugs is explained by the early start date
of this registry, which was significantly before the wide-
spread use of these drugs. Finally, the present cohort was
not evaluated rigorously for changes in quality of life or
other heart failure-related clinical events, such as the rates
of hospitalization. Such factors could be more directly af-
fected by changes in SV than mortality.
The recently released results of the STICH trial showed
that SVR in combination with CABG had no impact over
CABG alone on mortality, heart failure hospitalizations,
exercise tolerance, or quality of life.5 Several major limita-
tions of the STICH trial have already been noted,25 including
(1) patient inclusion bias (ie, many patients whose primary
surgeons considered SVR to be clinically indicated were
not randomized, characterized, or studied) and (2) a much
smaller than planned average reduction of EDV in the
SVR group (raising serious questions about whether the pro-
cedure was performed properly in a majority of cases). Nev-
ertheless, the overwhelmingly neutral results of that study
mandate that additional studies of SVR be carried out to
define its role in the care of patients with ischemic cardiomy-
opathy. It is reasonable to believe that after the STICH re-
sults, a widespread application of SVR to all patients with
ischemic cardiomyopathy is not warranted, and yet it is still
reasonable to hypothesize that a definable group of patients
exist who could benefit from SVR. Further clarification of
(1) ventricular properties associated with better hemody-
namic effects of SVR and (2) links between hemodynamic
effects and clinical outcomes could help define appropriate
patient selection criteria for this procedure.
CONCLUSIONS
Because of several limitations of the STICH trial,5 it is ex-
pected that SVR will continue to be performed in many cen-
ters, albeit possibly with reduced frequency. Investigators
will undoubtedly be motivated to understand factors that
identify patients who will benefit from this procedure. The
results of the present study potentially provide additional in-
sights by revealing that SVR can commonly result in a de-
crease in resting SV. The dissociation between reductions
in SV and overall survival is reassuring but does not pre-
clude an impact on other important aspects of overall patient
well-being. We identified baseline characteristics of the ex-
cluded region (ie, the degree of dyskinesia) that correlated
with the impact on SV, although the correlation was not
strong. We hypothesize, as suggested by theory, that more
detailed characterization of the excluded and non-excluded
regions, for example, as could be available from modern
magnetic resonance imaging, will lead to improved under-
standing of this matter. In addition, consistency of the surgi-1330 The Journal of Thoracic and Cardiovascular Surcal reconstruction procedure to reach target volumes,
assessment of additional measures of quality of life, and,
perhaps most important, assessment of exercise tolerance
and cardiac output at peak exercise would be important as-
pects of future studies of SVR.References
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FIGURE E1. Kaplan –Meier survival curves in patients whose stroke volume initially decreased compared with those whose stroke volume was initially
unchanged or improved. Survival is not significantly different in the 2 groups. SV, Stroke volume; SVR, surgical ventricular restoration.
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TABLE E1. Baseline demographics, medical treatments, and surgical
procedural characteristics
Survivors
(n ¼ 234)
Nonsurvivors
(n ¼ 14)
Values % Values % P value
Age (y) 65  9 69  9 .043
Male/female 192/42 82/18 11/3 78/22
Previous anterior MI
All MI, s 234 100 14 100
Q-wave MI, s 163 70 7 50
NYHA class 2.7  1.7 3.1  0.7 .0003
I 16 7 0 0
II 120 51 3 21
III 88 38 7 50
IV 10 4 4 29
Angina
Stable 90 38 4 29
Unstable 40 17 3 21
None 104 45 7 50
EF (%) 33  5 27  9 .0019
Medical therapy
ACE inhibitors 190 81 12 88
b-blockers 154 66 9 64
Aspirin 175 75 10 71
Diuretics 166 71 12 88
Statins 109 47 5 36
SVR procedure
Concomitant CABG 220 94 12 85
Anastomoses 2.7  1.4 2.9  1.2
Patch 155 66 10 72
MI, Myocardial infarction; NYHA, New York Heart Association; EF, ejection fraction;
ACE, angiotensin-converting enzyme; SVR, surgical ventricular restoration; CABG,
coronary artery bypass grafting. Values are expressed as mean  standard deviation
or n and%.
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